Krista Hodges
Physician Assistant · Knoxville, TNNPI 1457434227
Payments from drug & device makers
Across 77 payments — averaging $32.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$513
- Teleflex LLC$219
- Myovant Sciences Inc.$211
- Clarus Therapeutics Inc.$185
- Medtronic$168
- Urovant Sciences Inc$160
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,471100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 7 | $513 |
| Teleflex LLC | 2 | $219 |
| Myovant Sciences Inc. | 7 | $211 |
| Clarus Therapeutics Inc. | 12 | $185 |
| Medtronic | 3 | $168 |
| Urovant Sciences Inc | 5 | $160 |
| Astellas Pharma US Inc | 11 | $155 |
| Bayer | 2 | $139 |
| Kowa Pharmaceuticals America, Inc. | 2 | $127 |
| Antares Pharma, Inc. | 2 | $85 |
| Sumitomo Pharma America, Inc. | 5 | $80 |
| Eisai Inc. | 1 | $74 |
| Boston Scientific | 3 | $64 |
| 180 Medical, Inc. | 2 | $57 |
| Blue Earth Diagnostics | 2 | $53 |
| Tolmar Pharmaceuticals, Inc. | 2 | $40 |
| Endo Pharmaceuticals Inc. | 2 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| Tolmar, Inc. | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Halozyme Inc | 1 | $17 |
| Pfizer | 1 | $16 |
| AbbVie | 1 | $13 |
| Hollister Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,476 in reported general payments places this provider in the 80th percentile of 2,404 physician assistant providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 35 | $31,614 |
| GemtesaVibegron | 31 | $18,629 |
| ProgesteroneProgesterone, Micronized | 41 | $2,505 |
| Estradiol | 23 | $2,073 |
| Trimethoprim | 29 | $1,781 |
| Solifenacin Succinate | 37 | $1,777 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 52 | $1,241 |
| Tamsulosin Hcl | 83 | $1,208 |
| Desmopressin Acetate | 12 | $446 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $357 |
| Cephalexin | 11 | $333 |
| Finasteride | 17 | $142 |
| Sildenafil Citrate | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $155 | $31,61435 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $80 | $18,62931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Knoxville
- Lindsey NixKnoxville$576K
- Katherine RunyanKnoxville$156K
- Kevin BlazerKnoxville$20K
- Meghan ShotwellKnoxville$18K
- Timothy VanceKnoxville$13K
- Danielle WarrenKnoxville$11K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.